97 related articles for article (PubMed ID: 9838229)
1. An evaluation of the influence of devazepide and CCK-8S on the intact and resected rat liver.
Ohlsson B; Rehfeld JF; Axelson J
Eur Surg Res; 1998; 30(6):378-84. PubMed ID: 9838229
[TBL] [Abstract][Full Text] [Related]
2. The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.
Ohlsson B; Borg K; Rehfeld JF; Ihse I; Axelson J
Int J Pancreatol; 1998 Dec; 24(3):211-8. PubMed ID: 9873956
[TBL] [Abstract][Full Text] [Related]
3. CCK stimulates growth of both the pancreas and the liver.
Ohlsson B; Rehfeld JF; Axelson J
Int J Surg Investig; 1999; 1(1):47-54. PubMed ID: 11817337
[TBL] [Abstract][Full Text] [Related]
4. Devazepide-induced hyperplasia in the rat liver and bile ducts.
Ohlsson B; Axelson J; Rehfeld JF; Ihse I
Eur Surg Res; 1996; 28(4):299-305. PubMed ID: 8813655
[TBL] [Abstract][Full Text] [Related]
5. Continuous infusion of cholecystokinin leads to down-regulation of the cholecystokinin-A receptor in the rat pancreas.
Ohlsson B; Borg K; Mulder H; Rehfeld JF; Axelson J; Sundler F
Scand J Gastroenterol; 2000 Jun; 35(6):612-8. PubMed ID: 10912661
[TBL] [Abstract][Full Text] [Related]
6. The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin.
Axelson J; Fan BG; Ohlsson B; Rehfeld J; Ekelund M; Ihse I
Int J Pancreatol; 1996 Oct; 20(2):109-18. PubMed ID: 8968866
[TBL] [Abstract][Full Text] [Related]
7. The method of administration of cholecystokinin determines the effects evoked in the pancreas.
Ohlsson B; Borg K; Rehfeld JF; Axelson J; Sundler F
Pancreas; 2001 Jul; 23(1):94-101. PubMed ID: 11451154
[TBL] [Abstract][Full Text] [Related]
8. Total parenteral nutrition affects the tropic effect of cholecystokinin on the exocrine pancreas.
Fan BG; Axelson J; Sternby B; Rehfeld J; Ihse I; Ekelund M
Scand J Gastroenterol; 1997 Apr; 32(4):380-6. PubMed ID: 9140162
[TBL] [Abstract][Full Text] [Related]
9. The trophic response of rat pancreas to sulfated cholecystokinin-8 is dose- and time-dependent and not affected by vagotomy or atropine.
Nylander AG; Chen D; Ding XQ; Norlén P; Håkanson R
Pharmacol Toxicol; 1997 Mar; 80(3):142-6. PubMed ID: 9101587
[TBL] [Abstract][Full Text] [Related]
10. The trophic effect of cholecystokinin on the pancreas declines in rats on total parenteral nutrition.
Wu XM; Liao YW; Ji KQ; Li GF; Zang B
J Anim Physiol Anim Nutr (Berl); 2012 Apr; 96(2):214-9. PubMed ID: 21438927
[TBL] [Abstract][Full Text] [Related]
11. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.
Ohlsson B; Axelson J; Sternby B; Rehfeld JF; Ihse I
Int J Pancreatol; 1995 Aug; 18(1):59-66. PubMed ID: 7594771
[TBL] [Abstract][Full Text] [Related]
12. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats.
Lu L; Zhang B; Liu Z; Zhang Z
Brain Res; 2002 Nov; 954(1):132-40. PubMed ID: 12393241
[TBL] [Abstract][Full Text] [Related]
13. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
Gronier B; Debonnel G
Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
[TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin does not affect the pancreatic contents of epidermal growth factor or its receptor.
Ohlsson B; Rehfeld JF; Sundler F
Pancreas; 2000 Nov; 21(4):385-91. PubMed ID: 11075993
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of cholecystokinin-A receptor mRNA in pancreas and cholecystokinin-B receptor mRNA in oxyntic mucosa after porta-caval shunting in rats.
Nylander AG; von Friesen CP; Monstein HJ; Yamada H; Chen D; Boketoft A; Håkanson R
Pharmacol Toxicol; 1997 Mar; 80(3):147-51. PubMed ID: 9101588
[TBL] [Abstract][Full Text] [Related]
16. CCKB receptor activation results in increased [3H]thymidine incorporation in rat glioma C6 cells.
Kaufmann R; Henklein P; Nowak G
Neuropeptides; 1995 Nov; 29(5):241-4. PubMed ID: 8587658
[TBL] [Abstract][Full Text] [Related]
17. Selective CCK-A but not CCK-B receptor antagonists inhibit HT-29 cell proliferation: synergism with pharmacological levels of melatonin.
González-Puga C; García-Navarro A; Escames G; León J; López-Cantarero M; Ros E; Acuña-Castroviejo D
J Pineal Res; 2005 Oct; 39(3):243-50. PubMed ID: 16150104
[TBL] [Abstract][Full Text] [Related]
18. Central administration of cholecystokinin stimulates gastric pepsinogen secretion from anaesthetized rats.
Blandizzi C; Natale G; Carignani D; Colucci R; Lazzeri G; Del Tacca M
Neurosci Lett; 1995 Jun; 193(1):13-6. PubMed ID: 7566655
[TBL] [Abstract][Full Text] [Related]
19. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
Li Y; Hao Y; Owyang C
Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
[TBL] [Abstract][Full Text] [Related]
20. [Cholecystokinin octapeptide (CCK-8) antagonizes morphine analgesia in amygdala of the rat].
Pu SF; Han JS
Sheng Li Xue Bao; 1993 Oct; 45(5):470-8. PubMed ID: 8146670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]